The U.S. Securities and Exchange Commission has charged Futrex with fraud, claiming that the Dream Beam never worked. See Securities and Exchange Commission v. Futrex, Inc.
As of 1996, research on the Dream Beam has been stopped due to lack of funding. Field trials that had been planned at four eastern U.S. hospitals have been put off indefinitely. There are no plans for testing outside of the United States. Futrex has stopped mailing information about the product, again due to lack of funding.
Update: SEC obtains final judgements concluding the Futrex securities fraud case. (The article about Futrex is one-forth of the way down the page.)
The Dream Beam is supposed to be a non-invasive blood glucose measuring device under development by Futrex Medical Instrumentation, Incorporated of Gaithersburg, Maryland.
The Dream Beam is about 5 1/2" by 3" by 1 1/2" and operates on batteries. It is quite portable. It also requires individual calibration at this time. Pricing is expected to be equivalent to a current meter and one year of supplies, assuming six to eight blood tests a day (under US$2,500).
Futrex Medical Instrumentation, Incorporated
6 Montgomery Village Avenue, Suite 620
Gaithersburg, MD 20879
1-800-255-4206 (US Only)
(301) 670-1103 Fax
Last Updated: Thursday February 27, 2014 19:28:20
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.